000 02354 a2200625 4500
005 20250513141402.0
264 0 _c19980430
008 199804s 0 0 eng d
022 _a0023-852X
024 7 _a10.1097/00005537-199804000-00024
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCouloigner, V
245 0 0 _aEffect of locally applied drugs on the endolymphatic sac potential.
_h[electronic resource]
260 _bThe Laryngoscope
_cApr 1998
300 _a592-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
_xpharmacology
650 0 4 _aAcetazolamide
_xpharmacology
650 0 4 _aAcid-Base Imbalance
_xcomplications
650 0 4 _aAmiloride
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aBumetanide
_xpharmacology
650 0 4 _aCarbonates
_xantagonists & inhibitors
650 0 4 _aCarbonic Anhydrase Inhibitors
_xpharmacology
650 0 4 _aChloride Channels
_xantagonists & inhibitors
650 0 4 _aChlorothiazide
_xpharmacology
650 0 4 _aDiuretics
_xpharmacology
650 0 4 _aEndolymph
_xmetabolism
650 0 4 _aEndolymphatic Hydrops
_xetiology
650 0 4 _aEndolymphatic Sac
_xdrug effects
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aEpithelium
_xmetabolism
650 0 4 _aGuinea Pigs
650 0 4 _aIon Transport
_xdrug effects
650 0 4 _aMacrolides
650 0 4 _aMale
650 0 4 _aMembrane Potentials
_xdrug effects
650 0 4 _aMeniere Disease
_xetiology
650 0 4 _aOuabain
_xpharmacology
650 0 4 _aPotassium Channel Blockers
650 0 4 _aProton-Translocating ATPases
_xantagonists & inhibitors
650 0 4 _aSodium Channel Blockers
650 0 4 _aSodium Chloride
650 0 4 _aSodium Chloride Symporter Inhibitors
_xpharmacology
650 0 4 _aSodium-Hydrogen Exchangers
_xantagonists & inhibitors
650 0 4 _aSodium-Potassium-Exchanging ATPase
_xantagonists & inhibitors
650 0 4 _aTime Factors
700 1 _aLoiseau, A
700 1 _aSterkers, O
700 1 _aAmiel, C
700 1 _aFerrary, E
773 0 _tThe Laryngoscope
_gvol. 108
_gno. 4 Pt 1
_gp. 592-8
856 4 0 _uhttps://doi.org/10.1097/00005537-199804000-00024
_zAvailable from publisher's website
999 _c9513719
_d9513719